PMID:22014014: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
imported>Wikientrybot
replace GO_table_reference with annotationlinks
imported>Wikientrybot
change PMID template to TableEdit version
 
Line 12: Line 12:
!align=left  |Citation
!align=left  |Citation
||
||
'''Mahajan, A and Gally, D'''  (2011) Escherichia coli and the mucosal immune system.''Expert Rev Clin Immunol'' '''7''':743-5
'''Mahajan, A and Gally, D'''  (2011) Escherichia coli and the mucosal immune system. ''Expert Rev Clin Immunol'' '''7''':743-5
|-
|-
!align=left  |Abstract
!align=left  |Abstract
Line 25: Line 25:
!align=left  |Keywords
!align=left  |Keywords
||
||
Animals; Belgium; Congresses as Topic; Escherichia coli Infections; Escherichia coli Vaccines; Germany; Hemolytic-Uremic Syndrome; Humans; Immunity, Mucosal; Shiga-Toxigenic Escherichia coli; Vaccination
Animals; Belgium; Congresses as Topic; Escherichia coli Infections/immunology; Escherichia coli Infections/mortality; Escherichia coli Infections/prevention & control; Escherichia coli Vaccines/immunology; Escherichia coli Vaccines/therapeutic use; Germany/epidemiology; Hemolytic-Uremic Syndrome/immunology; Hemolytic-Uremic Syndrome/mortality; Hemolytic-Uremic Syndrome/prevention & control; Humans; Immunity, Mucosal; Shiga-Toxigenic Escherichia coli/immunology; Shiga-Toxigenic Escherichia coli/pathogenicity; Vaccination


|- class="tableEdit_footer"  
|- class="tableEdit_footer"  
Line 31: Line 31:
|}
|}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181206.E4f8733c4cb250-->
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181206.E4f8733c4cb250-->
==Significance {{HelpIcon|Help:Literature}} ==
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
{{LitSignificance}}

Latest revision as of 04:41, 15 September 2013

Citation

Mahajan, A and Gally, D (2011) Escherichia coli and the mucosal immune system. Expert Rev Clin Immunol 7:743-5

Abstract

The meeting was held in the beautiful city of Ghent, Belgium, to bring together basic scientists and clinicians working on Escherichia coli and the mucosal immune system; in particular focusing on cellular interactions, immune modulation and vaccination strategies in humans and animals. The aim was to exchange knowledge on the pathogenicity of different types of E. coli and recent advances in the area of mucosal immunity. The meeting was timely given the recent outbreak in northern Germany of an emergent Shiga toxigenic E. coli strain that was associated with the deaths of over 45 people and caused hemolytic uremic syndrome in nearly 800 individuals according to the European Centre for Disease Prevention and Control.

Links

PubMed Online version:10.1586/eci.11.68

Keywords

Animals; Belgium; Congresses as Topic; Escherichia coli Infections/immunology; Escherichia coli Infections/mortality; Escherichia coli Infections/prevention & control; Escherichia coli Vaccines/immunology; Escherichia coli Vaccines/therapeutic use; Germany/epidemiology; Hemolytic-Uremic Syndrome/immunology; Hemolytic-Uremic Syndrome/mortality; Hemolytic-Uremic Syndrome/prevention & control; Humans; Immunity, Mucosal; Shiga-Toxigenic Escherichia coli/immunology; Shiga-Toxigenic Escherichia coli/pathogenicity; Vaccination

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

<annotationlinks/>

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

See also

References

See Help:References for how to manage references in EcoliWiki.